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Whyaregenesharmfulwhen theyareoverexpressed?
By testing possible causes of overexpression pheno-
types in yeast, we identify intrinsic protein disorder
as an important determinant of dosage sensitivity.
Disordered regions are prone to make promiscuous
molecular interactions when their concentration is
increased, and we demonstrate that this is the likely
cause of pathology when genes are overexpressed.
We validate our findings in two animals, Drosophila
melanogaster and Caenorhabditis elegans. In mice
and humans the same properties are strongly associ-
ated with dosage-sensitive oncogenes, such that
mass-action-driven molecular interactions may be
a frequent cause of cancer. Dosage-sensitive genes
are tightly regulated at the transcriptional, RNA, and
protein levels, which may serve to prevent harmful
increases in protein concentration under physiolog-
ical conditions. Mass-action-driven interaction pro-
miscuity is a single theoretical framework that can
be used to understand, predict, and possibly treat
the effects of increased gene expression in evolution
and disease.
INTRODUCTION
Most of the genetic variation between any two individuals or
species consists of regulatory or copy number variants that alter
gene expression rather than coding sequence (Stranger et al.,
2007). Despite the importance of altered gene expression to
disease andevolution, it is not understoodwhyonly certain genes
are pathological when their expression is increased (are dosage
sensitive), and what the molecular mechanisms are that drive
these phenotypic changes (Semple et al., 2008). Indeed there
are no known molecular mechanisms that are predictive of
dosage sensitivity across the genome of an organism (Gelperin
et al., 2005; Semple et al., 2008; Sopko et al., 2006). As a result,
it is currently very difficult to understand the consequences of
increased gene expression in either disease or evolution.198 Cell 138, 198–208, July 10, 2009 ª2009 Elsevier Inc.In yeast, 80% of genes can be constitutively overexpressed
without any severe detrimental effect on growth (Gelperin et al.,
2005; Sopko et al., 2006). In contrast a subset of genes are harm-
ful when overexpressed. These dosage-sensitive genes are en-
riched for diverse and multiple functions (Gelperin et al., 2005;
Sopko et al., 2006), and they do not significantly overlap the
set of genes that are harmful when their expression is decreased
(Deutschbauer et al., 2005; Semple et al., 2008). Unlike essential
genes, dosage-sensitive genes are not enriched among the
subunits of protein complexes (Sopko et al., 2006). Moreover,
whereas the loss-of-function phenotype of one subunit of
a protein complex is highly predictive of the loss-of-function
phenotype of the other subunits (Fraser and Plotkin, 2007; Hart
et al., 2007), this is not true for overexpression phenotypes
(Semple et al., 2008). Indeed, in the majority of cases examined
overexpression causes phenotypic effects that are different from
underexpression (Niu et al., 2008; Sopko et al., 2006). It has also
been shown that dosage-sensitive genes are only very weakly
enriched for cell-cycle-regulated genes (Sopko et al., 2006), so
forced expression of periodically expressed genes cannot be
a major cause of phenotypic change. In short, it is not under-
stood why cells function robustly following the overexpression
of most genes but are very sensitive to increases in the levels
of a subset of genes. It is also not clear what the most important
molecular mechanisms are that cause gain-of-function pheno-
types following gene overexpression.
To resolve this, we systematically tested possible causes of
dosage sensitivity in yeast. We find that the intrinsic disorder
content of a protein is an important determinant of dosage sensi-
tivity. These disordered regions are prone to make promiscuous
molecular interactions when their concentration is increased,
and we present evidence that this is a frequent cause of dosage
sensitivity. We confirm our findings in two animals, Drosophila
melanogaster and Caenorhabditis elegans, and we show that
the properties of dosage-sensitive genes detected in model
organisms are also strongly associated with dosage-sensitive
oncogenes in mice and humans. Finally, we show that dosage-
sensitive genes are tightly regulated at the transcriptional,
RNA, and protein levels, and we argue that this control acts to
prevent potentially harmful increases in protein concentration
under physiological conditions. The interaction promiscuity
theory yields predictions for future experimental studies and
Figure 1. Features that Predict Dosage-Sensitive Genes in Yeast
Twenty-seven genomic and experimental features tested for their ability to predict dosage-sensitive genes in yeast by measuring the average area under
a receiver operating characteristic (ROC) curve in a tenfold cross-validation experiment. The features and their correlations with dosage sensitivity are described
in Table S1. Features that are significantly predictive are indicated, **p < 0.01, *p < 0.05 (one-tailed t test). Error bars show the 95% confidence interval for each
predictor.provides a single theoretical framework for understanding, pre-
dicting, and potentially treating dosage sensitivity in disease
and evolution.
RESULTS
Testing Possible Determinants of Dosage
Sensitivity in Yeast
Loss-of-function phenotypes resulting from decreased gene
expressioncanbeglobally predicted inbothunicellular andmulti-
cellular animals (Lee et al., 2008; Pena-Castillo et al., 2008). In
contrast, the genes that are harmful when their expression levels
are increased cannot be predicted, primarily because the mech-
anisms that drive overexpression phenotypes are unknown
(Gelperin et al., 2005; Semple et al., 2008; Sopko et al., 2006).
In the budding yeast Saccharomyces cerevisiae 18% of
genes have a detrimental effect on growth when their expression
is increased (Gelperin et al., 2005; Sopko et al., 2006). In most
cases the overexpression phenotypes differ from loss-of-func-
tion phenotypes, suggesting that they normally represent gain-
of-function effects (Gelperin et al., 2005; Semple et al., 2008;
Sopko et al., 2006). Some of these phenotypic changes mayresult from the ‘‘misexpression’’ of a regulatory gene in a condi-
tion in which that gene is not normally expressed (Sopko et al.,
2006). However, this cannot explain the vast majority of overex-
pression phenotypes. First, nearly all of the genes that are harm-
ful when overexpressed are constitutively expressed during
normal growth (93%; Holstege et al., 1998). Second, 87% of
them have expression patterns that do not alter in level during
the cell division cycle during normal growth (Gauthier et al.,
2008). Third, 85% of them do not encode proteins that are
considered to have regulatory functions (Segal et al., 2003).
Therefore, misexpression is likely to explain only a few cases
of overexpression phenotypes.
To identify alternative causes of dosage sensitivity, we tested
a total of 27 genomic and experimental features for their relation-
ship with overexpression phenotypes and used cross-validation
to assess the use of each feature as a predictor of dosage sensi-
tivity (see Experimental Procedures and Table S1). Among the
features for which we find no relationship with dosage sensitivity
are the abundance of an mRNA, the number of protein complex
interactions, the aromaticity of a protein, the underwrapping of
a protein (a measure of backbone exposure), and the aggrega-
tion propensity of a protein (Figure 1). Thus, for most genes,Cell 138, 198–208, July 10, 2009 ª2009 Elsevier Inc. 199
sensitivity to a dosage increasemust be caused by amechanism
distinct from misassembly of protein complexes, forced misex-
pression, or protein aggregation.
Intrinsic Protein Disorder and Linear Motif Content
Are Predictive of Dosage Sensitivity
Many proteins contain both structured regions and intrinsically
unstructured, or disordered, regions (Russell and Gibson, 2008).
We find that the content of these intrinsically disordered regions
is a good predictor of dosage sensitivity in yeast (r = 0.94, p =
2.9 3 105, Figure 2). This is seen using three alternative
measures of intrinsic disorder (Figure 1). Moreover the strong
relationship with disorder is seen when only considering genes
with low (Figure 2B), medium (Figure 2C), or high (Figure 2D)
levels of endogenous expression. It is also very strong when
excluding all genes with expression levels that change during
the cell cycle (Figure 2E) andwhen excluding all regulatory genes
(Figure 2F). Disorder is therefore predictive of dosage sensitivity
for many different types of genes in yeast.
To understand the mechanism that connects disordered
regions to dosage sensitivity it is necessary to consider the func-
tions of these regions. Unstructured protein regions are impor-
tant because they contain short, linear functional sites within
proteins (Russell and Gibson, 2008). Many recognition events
within a cell—for example protein associations and posttransla-
tional modifications—are mediated by the binding of globular
protein domains to linear peptide sequence motifs contained
within unstructured regions (Castagnoli et al., 2004; Collins
et al., 2008; Russell and Gibson, 2008). It is possible therefore
that dosage sensitivity is related to the ability of proteins to
make molecular interactions via linear sequence motifs. Indeed,
predicting instances of known linear motifs (Obenauer et al.,
2003) across the yeast proteome shows that the number of
known linear motifs within a protein is also highly correlated
with dosage sensitivity (r = 0.91, p < 2.3 3 104). That is, both
the intrinsic disorder content (Figures 2A–2F) and the linear motif
content (Figure 2G) of a protein are predictive of dosage sensi-
tivity in yeast.
The Interaction Promiscuity Hypothesis
The binding of two molecules depends not just on their affinity
but also on their concentration. That is, as a simple consequence
of mass action, any two molecules will associate if their concen-
tration is high enough. Within a cell, many proteins have both
physiological targets to which they bind with high affinity as
well as additional targets to which they will bind if their concen-
tration is increased. For high-affinity molecular interactions
mediated via the large and complex interaction interfaces of
two globular domains there are few potential ‘‘off target’’ interac-
tions within a cell. In contrast, for interactions mediated by short
linear motifs—for example the recognition of linear peptide
motifs or the binding of transcription factors to DNA—there are
many potential off target interactions with only marginally
reduced affinities. This is because linear motifs are short and
degenerate and so occur at high frequencies by chance in bio-
logical sequences (Diella et al., 2008; Russell and Gibson,
2008). Moreover, motif-binding protein domains are present in
families of proteins with very similar binding site preferences200 Cell 138, 198–208, July 10, 2009 ª2009 Elsevier Inc.and so will bind to each others’ physiological targets if their
concentration is increased (Diella et al., 2008; Russell and
Gibson, 2008). For example, proteins containing SH3 domains
bind to sequence motifs based on the consensus sequence
PxxP, and the binding site preferences of individual proteins
are both highly promiscuous and overlapping (Tong et al.,
2002). Thus the profile and promiscuity of the interactions of
proteins that contain linear motifs, or that are able to bind to
linear motifs, are inherently sensitive to increases in protein
concentration (Jones et al., 2006).
We propose that it is this potential for concentration-depen-
dent interaction promiscuity, mediated via linear motif interac-
tions, that is a major cause of dosage sensitivity in yeast.
Dosage Sensitivity Correlates with Binary
Protein Interaction Degree
As a test of the interaction promiscuity theory, we asked whether
there is any relationship between the number of protein interac-
tions known for a protein and its likelihood of being dosage sensi-
tive. As predicted by the hypothesis, there is (Figure 3A). Proteins
that havemore known binary interaction partners aremuchmore
likely to be dosage sensitive (r = 0.92, p = 1.63 104). This is not
true when considering stable (high-affinity) interactions that can
be identified using purification techniques (Figure 1, Table S1
available online) but only when considering binary interactions
detected by sensitive interaction assays. This is exactly what is
expected from the interaction promiscuity hypothesis, which
predicts that it is the number of potential low-affinity interactions
that is the important determinant of dosage sensitivity.
Linear Motif-Binding Proteins Are Dosage Sensitive
A further prediction of the promiscuity theory is that if linear motif
interactions are an important cause of dosage sensitivity, then
not just linear motif-containing proteins but also linear motif-
binding proteins should be dosage sensitive. Increasing the
concentration of a protein that can bind to short linear motifs
should cause mass-action-driven promiscuous interactions
just as increasing the concentration of a motif-containing protein
does. To test this, we compiled a set of yeast proteins that
contain domains that recognize linear sequence motifs and
asked whether these proteins are also more likely to be dosage
sensitive: they are (Figure 3B). Proteins that can bind to linear
motifs are highly dosage sensitive (p = 6.7 3 1015). Thus both
linear motif-containing and linear motif-binding proteins are
dosage sensitive, in agreement with the promiscuity hypothesis.
Dosage Sensitivity in Drosophila
In yeast we find that four measures of the potential of a protein to
make promiscuous molecular interactions when overex-
pressed—the disorder content, the linear motif content, binary
protein interaction degree, and the ability to bind linear motifs—
are all predictive of dosage sensitivity. To test the generality of
this result, we asked whether the same four measures are also
predictive of dosage sensitivity in a second species, the fly
Drosophila melanogaster. We used systematic data from
screens in which 1000 genes have been overexpressed in
specific tissues and their phenotypic consequences assayed
(Rorth, 1996; Toba et al., 1999). Just as in yeast, we find that
Figure 2. Intrinsic Protein Disorder and Linear
Motif Content Are Associated with Dosage
Sensitivity in Yeast
(A) There is a very good correlation between the total
length of intrinsically disordered regions within
a protein and dosage sensitivity in yeast (Spearman’s
rank correlation coefficient r = 0.94, p = 2.9 3 105).
This correlation is still strong after normalizing by
protein length (Figure S1A). The strong relationship
between dosage sensitivity and intrinsic disorder is
also seen when only considering genes with low (B),
medium (C), or high (D) levels of endogenous expres-
sion (Beyer et al., 2004). It is also seen when excluding
all genes with cell-cycle-regulated (Gauthier et al.,
2008) expression patterns (E) and when excluding all
regulatory genes (Segal et al., 2003) (F). There is also
a strong correlation between the number of predicted
linear motifs (Obenauer et al., 2003) a protein contains
and its dosage sensitivity (r = 0.91, p = 2.43 104) (G).
The effect is still strong after normalizing by protein
length (Figure S1B). Also, the trend is strong when
only considering either enzymatic motif-binding sites
(Chi squared test for trend, p = 5.1 3 1011) or nonen-
zymatic motif-binding sites (Chi squared test for trend,
p = 2.8 3 103). The dashed lines indicate the
frequency of dosage-sensitive genes for the whole
yeast genome.Cell 138, 198–208, July 10, 2009 ª2009 Elsevier Inc. 201
all four predictions of the interaction promiscuity theory are vali-
dated in an animal. The intrinsic disorder content (r = 0.83,
p = 3.2 3 105, Figure 4A), the linear motif content (r = 0.78,
p = 8.0 3 103, Figure 4B), the number of binary interactions
(r = 0.73, p = 0.01, Figure 4C), and the ability to bind to linear
motifs (Fisher’s exact test, p = 2.2 3 103, Figure 4D) are all
predictive of dosage sensitivity.
We conclude that the potential for concentration-dependent
interaction promiscuity is predictive of dosage sensitivity in
both yeast and flies.
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Figure 4. Dosage Sensitivity in Drosophila
melanogaster and Caenorhabditis elegans
Just as in S. cerevisiae, in D. melanogaster the
intrinsic disorder content (A) (r = 0.83, p = 3.2 3
105), the linear-motif content (B) (r = 0.78, p =
8.0 3 103), the number of binary protein interac-
tions (C) (r = 0.73, p = 0.01), and the ability to
bind to linear motifs (D) (p = 2.23 103) are predic-
tive of dosage sensitivity.
(E) Integrating information on intrinsic disorder,
binary interaction degree, and linear motif binding,
we predicted dosage-sensitive genes inC. elegans
(see Experimental Procedures). We overexpressed
8 of these genes and found that 6 (75%) induced
embryonic lethality. The horizontal line indicates
the background rate of lethality following heat
shock. **p < 0.01, *p < 0.05 (Fisher’s exact test).
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A B Figure 3. Dosage-Sensitive Genes in Yeast
Have Many Binary Protein Interactions and
Bind to Short Linear Motifs
(A) There is a good correlation between the number
of binary protein interactions known for a protein
and its dosage sensitivity (r = 0.92, p = 1.6 3
104). Moreover, just as linear motif content is
predictive of dosage sensitivity (Figure 2), so is the
ability to bind to linear motifs (B) (p = 6.7 3 1015,
Fisher’s exact test). The same result is seen when
only considering either enzymatic motif-binding
domains (p = 2.94 3 105) or nonenzymatic motif-
binding domains (p = 5.35 3 1011).202 Cell 138, 198–208, July 10, 2009 ª2009 Elsevier Inc.
Predicting Dosage Sensitivity in C. elegans
To further confirm our findings, we integrated information on
protein disorder, linear motif binding, and protein interaction
degree to predict dosage-sensitive genes in a third species,
the nematode Caenorhabditis elegans (see Experimental Proce-
dures). We tested 8 of the most highly ranked genes and verified
6 (75%) as causing lethality when overexpressed (Figure 4E).
Figure 5. Dosage Sensitivity and Cancer in Mice
and Humans
Intrinsic disorder (A) (r = 0.93, p < 2.23 1016), linear motif
content (B) (r = 0.74, p = 0.013), binary protein interaction
degree (C) (r = 0.91, p = 2.2 3 104), and linear motif
binding (D) (p < 2.2 3 1016) are all also highly associated
with dosage-sensitive genes that cause cancer when acti-
vatedby retroviral insertion inmice (Akagi et al., 2004). In (A)
to (C) the recall of oncogenes is shown for each equally
sized bin of genes. As in mice, intrinsic disorder (E) (r =
0.92, p = 1.6 3 104), linear motif content (F) (r = 0.89,
p = 1.1 3 103), binary protein interaction degree (G) (r =
0.83, p = 2.9 3 103), and linear motif binding (H) (p =
2.2 3 1016) are highly associated with dosage-sensitive
genes that cause cancer when activated in humans. The
relationship between protein interaction degree and
dosage sensitivity is also seen when only using data from
high-throughput assays and so is not an artifact of ascer-
tainment bias (data not shown). In (E) to (G) the recall of
oncogenes is shown for each equally sized bin of genes.
Thus using criteria and parameters derived
from yeast, we are able to successfully predict
dosage-sensitive genes in C. elegans.
Dosage Sensitivity in Mice
To test whether our findings also apply to
mammals, we considered dosage-sensitive
genes that are oncogenic when overexpressed.
In mice these genes have been systematically
identified in genetic screens using the integration
of retroviruses toactivategeneexpression (Akagi
et al., 2004). As in yeast, flies, and worms, these
dosage-sensitive genes are strongly associated
with protein disorder (Figure 5A) and have the
presence of many linear motifs (Figure 5B),
a high binary protein interaction degree (Fig-
ure 5C), and the ability to bind to linear motifs
(Figure 5D). Thus the sameproperties associated
with dosage-sensitive genes in yeast are able to
predict dosage-sensitive cancer genes in mice.
Dosage Sensitivity in Human Cancer
In humans, the small set of genes that are known
to be causally amplified in cancer are also
strongly enriched for disorder (p = 5.8 3 104,
Wilcoxon rank sum test), linear motifs (p =
4.9 3 104), binary protein interactions (p =
0.035), and the ability to bind to linear motifs
(p = 5.0 3 109). This is also true of a larger
set of oncogenes activated by either amplifica-
tion or translocation (Figures 5E–5G). Thus, as in mice,
dosage-sensitive oncogenes share the same properties as
dosage-sensitive genes in model organisms.
We conclude that the properties of dosage-sensitive genes
that we identify in yeast are also conserved for dosage-sensitive
genes in mice and in human disease. Thus the principle of
mass-action-driven interaction promiscuity can be used toCell 138, 198–208, July 10, 2009 ª2009 Elsevier Inc. 203
Figure 6. Dosage-Sensitive Genes Are Tightly Regulated and Rapidly Cleared to Prevent Harmful Increases in Protein Concentration
Dosage-sensitive genes in yeast have more extensive (A) and more conserved (B) upstream regulatory regions, slower transcription rates (C), larger 50 (D) and 30
(E) untranslated regions in their mRNAs, and lower translation rates (F). Dosage-sensitive genes also have faster rates of mRNA decay (G) and protein degradation
(H), ensuring that they are rapidly cleared from the cell after use and resulting in lower overall protein abundances (I). They are also more likely to have overlapping
antisense transcripts (J). All plots for quantitative variables are shown for ten evenly sized bins of genes, ranked according to the variable under consideration.
Spearman’s rank correlation coefficients (and p values): (A) 0.81 (7.5 3 103), (B) 0.93 (8.2 3 105), (C) 0.66 (3.0 3 102), (D) 0.89 (5.5 3 104), (E) 0.87 (1.0 3
103), (F) 0.88 (2.0 3 105) (G) 0.66 (3.8 3 102), (H) 0.83 (3.0 3 103), (I) 0.79 (6.5 3 103). For (J), p = 0.014 by Fisher’s exact test.successfully predict dosage sensitivity across many different
species.
Dosage-Sensitive Gene Products Are Tightly Regulated
and Rapidly Degraded in Yeast
Genes that are harmful when overexpressed should be tightly
regulated to prevent such harmful increases under physiological204 Cell 138, 198–208, July 10, 2009 ª2009 Elsevier Inc.conditions. To test this prediction we used global datasets on
gene regulation in yeast. In short, we find that this is the case,
and that dosage-sensitive genes are tightly regulated at many
levels.
At the DNA level, genes with overexpression phenotypes have
both larger (Figure 6A) andmore conserved (Figure 6B) upstream
regions, reflecting tighter transcriptional control (Chin et al.,
Figure 7. Mass-Action-Driven Interaction
Promiscuity
As a result of mass action, increasing the concen-
tration of a protein can dramatically alter its profile
of cellular interactions. High-affinity domain-
domain interactions have complex binding inter-
faces and very few potential ‘‘off-target’’ interac-
tions. Their interaction profiles therefore change
little in response to alterations in protein concen-
tration (A). In contrast interactions with short,
degenerate linear motifs are low affinity and have
many potential off-target interactions within a cell
due to the large families of motif-binding proteins
and the high frequency of motifs and disordered
regions in proteins (B) (Castagnoli et al., 2004;
Neduva and Russell, 2005). The profiles of linear motif interactions in a network can therefore become much more promiscuous following increases in pro-
tein concentration. This is further illustrated in the phase-plane diagram shown in (C), which shows the sensitivity of linear motif interactions to changes
in free protein concentration over realistic ranges of dissociation constants (KD) (Neduva and Russell, 2005) and cellular concentrations (Wu and Pollard,
2005). As the free concentration of a protein (A) is increased it will interact both with physiological targets (A + T4 AT) and also with off-target molecules
(A + OT4 AOT) to which it binds with lower affinity. Fraction bound is the proportion of target (T) or off-target (OT) proteins bound to protein A.2005). They also have a lower rate of transcription (Figure 6C). At
the mRNA level they have both larger 50 (Figure 6D) and 30
(Figure 6E) untranslated regions and faster rates of mRNA turn-
over (Figure 6G). They also have a lower translation rate (Fig-
ure 6F) and are subject to rapid degradation at the protein level
(Figure 6H), and as a result, they have lower overall protein levels
(Figure 6I). Dosage-sensitive genes are also more likely to have
overlapping antisense transcripts (Figure 6J), suggesting a
negative (or positive; Faghihi et al., 2008) role for antisense tran-
scription in the regulation of dosage-sensitive genes. The tight
regulation of dosage-sensitive genes is also seen when only
considering disordered proteins (Figure S2, Gsponer et al.,
2008), proteins with a high linear motif content (Figure S3),
proteins with a high protein interaction degree (Figure S4), or
proteins that bind to linear motifs (Figure S5).
We conclude that dosage-sensitive genes, and gene products
that have the potential to make promiscuous interactions, are
tightly regulated in yeast and, in particular, that they are slowly
producedand rapidly clearedatboth themRNAandprotein levels.
These regulatory ‘‘safety mechanisms’’ may act to limit harmful
accumulations of protein concentration during normal growth.
DISCUSSION
Mass-Action-Driven Interaction Promiscuity
and the Mechanisms of Dosage Sensitivity
Withinanycell thereare tensof thousandsof physical interactions
that canoccur betweenmacromolecules. Although they areoften
represented as static structures, these networks of molecular
interactions actually have topologies that alter in response to
changes in protein concentration (Figure 7). As a consequence
of mass action, an increase in the concentration of a protein
can result in that protein making more promiscuous molecular
interactions. What we term the interaction promiscuity hypoth-
esis states that it is these promiscuous molecular interactions,
primarily involving linear sequencemotifs, that drive pathological
changes in response to increased gene dosage (Figure 7).
In yeast there is good evidence that interaction promiscuity is
a major cause of dosage sensitivity. First, the intrinsic disordercontent of a protein is a good predictor of dosage sensitivity in
this organism. Second, the more linear motifs a protein contains,
and the more binary protein interactions that are known for
a protein, the more likely it is to be dosage sensitive. Third,
proteins that can bind to linear motifs are also highly dosage
sensitive.
The same four measures of the potential for interaction
promiscuity—intrinsic disorder, linear motif content, protein
interaction degree, and motif binding—are all also predictive of
dosage sensitivity in an animal, Drosophila melanogaster.
Further, using the same four measures, it is possible to success-
fully predict de novo dosage-sensitive genes in a third species,
C. elegans. We conclude that the potential for interaction
promiscuity, mediated via linear motifs, is widely associated
with dosage-sensitive genes across eukaryotes.
Interaction Promiscuity in Human Disease
The properties of dosage-sensitive genes in yeast, flies, and
worms are also strongly associated with dosage-sensitive onco-
genes in both mice and humans. It seems therefore that interac-
tion promiscuity may provide a general method for predicting the
changes in gene expression that are most likely to be patholog-
ical in humans. In any disease there are often many genes over-
expressed or upregulated, and a central challenge for human
genetics is to identify which of these are etiologically important.
Interaction promiscuity provides one framework to do this.
Two previous observations also support our findings. First,
protein kinases that are activated in cancer have more promis-
cuous substrate specificities than other kinases (Miller et al.,
2008). Second, a quantitative study of the interactions of
members of the ErbB family of cell-surface receptors showed
that oncogenic family members become more promiscuous in
their interactions when overexpressed (Jones et al., 2006). Again
this is consistent with ectopic interactions being a widespread
cause of gain-of-function phenotypes.
In animals, mass-action-driven interaction promiscuity also
predicts an additional class of genes that should be particularly
dosage sensitive—miRNAs. The interactions of miRNAs also
depend on short, degenerate sequence motifs that are foundCell 138, 198–208, July 10, 2009 ª2009 Elsevier Inc. 205
in very many cellular mRNAs. These interactions should also
therefore be sensitive to overexpression. Consistent with this,
there are many examples of miRNAs that are known to be path-
ological when overexpressed (Table S2). It is likely that many of
these effects result from the concentration-dependent binding of
miRNAs to nonphysiological target sequences.
Finally, our findings suggest that it may be possible to alleviate
dosage-sensitive phenotypes in humans by using competitive
inhibitors of linear motif interactions. The interactions of proteins
with linear sequence motifs, which normally bind in deep surface
clefts, are intrinsically more ‘‘druggable’’ than other protein inter-
actions (Russell and Gibson, 2008) and so represent good candi-
dates for therapeutic intervention.
Concluding Remarks
Most importantly, we demonstrate here a molecular mechanism
that is widely predictive of dosage sensitivity, and one that is
predictive across many different species. This makes it possible
to consider predicting the effects of both decreased (Lee et al.,
2008; Pena-Castillo et al., 2008) and increased gene expression
in disease and evolution. Our findings highlight the importance of
considering global interaction networks as having dynamic, not
static, structures, and it is likely that further work in this area
will illuminate many other areas of biology.
EXPERIMENTAL PROCEDURES
Testing Features for Their Ability to Predict Dosage Sensitivity
in Yeast
Yeast genes with overexpression phenotypes were identified in two genome-
wide screens (Gelperin et al., 2005; Sopko et al., 2006). There are a total of 839
genes with overexpression phenotypes out of 4591 genes tested. The
complete set of sequence and experimental features tested for their ability
to predict dosage sensitivity are described in Table S1. For each feature we
first tested for a correlation between the feature and dosage sensitivity (Table
S1). We then used a tenfold cross-validation experiment to test the ability of
each feature to predict dosage-sensitive genes. We use the mean area under
a receiver operating characteristic (ROC) curve for each of the cross-validation
experiments as a measure of the performance of each feature as a predictor
(Figure 1, Table S1).
Intrinsically Disordered Regions
Intrinsically disordered regions were identified using Globplot (Linding et al.,
2003) using the default settings and using DisEMBL as described (Beltrao
and Serrano, 2005). Genes were classified as low, medium, and highly
expressed using three equally sized bins (Beyer et al., 2004). Cell-cycle-modu-
lated genes were identified using the data from Cyclebase.org (Gauthier et al.,
2008). Regulatory genes were taken from the classification of Segal et al.
(2003).
Linear Motif Content
Predicted instances of known linearmotifs were identified using Scansite 2.0 in
the most stringent setting and using the following motif families relevant to
yeast: pST_bind, SH3, acid_ST_kin, baso_ST_kin, DNA_dam_kin, Pro_ST_kin,
kin_bind, PDZ (Obenauer et al., 2003). For the distinction between enzymatic
and nonenzymatic motifs, we used the following grouping: pST_bind, SH3,
and PDZ as nonenzymatic and the remainder as enzymatic.
Protein Interactions
Yeast protein interactions were downloaded from BioGRID 2.0.33 (Stark et al.,
2006). We divided the interaction data into two sets—those detected by affinity
purification methods (protein complex interactions), and those only detected
by other methods (binary interactions). There are a total of 27,517 and206 Cell 138, 198–208, July 10, 2009 ª2009 Elsevier Inc.13,142 interactions in each dataset for the proteins tested for overexpression
phenotypes.
Linear Motif-Binding Proteins
Linear motif-binding proteins are proteins containing protein domains that are
known tobind to linear peptidemotifs, as listed (Diella et al., 2008) (Interpro iden-
tifiers [Mulder et al., 2007] and the number of tested proteins are indicated, total
n = 324 proteins in yeast): SH3 (IPR001452, 21), 14-3-3 (IPR000308, 2), PDZ
(IPR001478, 2), EVH1 (IPR000697, 1), VHS (IPR002014, 4), FHA (IPR000253,
15), EH (IPR000261, 4), BRCT (IPR001357, 9), Bromo (IPR001487, 9), Chromo
(IPR000953, 4), GYF (IPR003169, 3), ER retention receptor (IPR000133, 1),
kinase (IPR011009,122), Ser/Thr phosphatase (IPR006186,12), dual-specificity
phosphatase (IPR000340, 6), plus sequence-specific DNA-binding proteins
(118; MacIsaac et al., 2006). For the distinction between enzymatic and nonen-
zymatic motif-binding proteins, we used the following grouping: kinase, Ser/
Thr phosphatase, and dual-specificity phosphatases as enzymatic and the
remainder as nonenzymatic.
Gene Regulation
Upstream intergenic distances were calculated from the SGD database (ftp://
ftp.yeastgenome.org/yeast/). The following additional genomic datasets were
used: transcription rate (Garcia-Martinez et al., 2004); mRNA half-life (Wang
et al., 2002); protein half-life (Belle et al., 2006); translation rate (Beyer et al.,
2004); protein abundance (Beyer et al., 2004); antisense transcripts (David
et al., 2006); upstream conservation (the fraction of the upstream region over-
lapping with sequences conserved in 7 yeast species (Gustafson et al., 2006));
and 50 and 30UTR lengths (Nagalakshmi et al., 2008).
Drosophila Datasets
Genes tested for overexpression phenotypes in flies using the Gal4-driven
overexpression system (Rorth, 1996; Toba et al., 1999) were downloaded
from Flybase on December 2, 2008 (Crosby et al., 2007). A total of 1068 genes
have been tested in overexpression screens, of which 279 have a reported
morphological overexpression phenotype in Flybase. These data are available
as Table S3. Protein interactions (a total of 4821 binary protein-protein interac-
tions), motif-binding domains, linear motifs, and disorder predictions were
defined as for yeast, with the addition of tyrosine kinase (Y_kin), SH2 motifs,
and the SH2 domain (IPR000980).
Predicting and Testing Dosage-Sensitive Genes in C. elegans
We predicted dosage-sensitive genes in C. elegans using a generalized linear
model fitted on the yeast data to rankC. elegans genes according to their likeli-
hood of being dosage sensitive (0.004D + 0.009PI + 0.587L + 1.914,measuring
the number of disordered residues [‘‘D’’] and the ability to bind to linear motifs
[‘‘L’’] as defined for Drosophila, as well as binary protein interaction degree
(‘‘PI’’) using the dataset of Simonis et al., 2009). We focused on genes between
1 and 1.2 kb to facilitate cloning (a total of 2801 genes) and tested the first 8 of
the top 20 ranked genes for which we obtained transgenic animals. Open
reading frames were cloned into the heat-shock-inducible promoter vectors
pMB1 and pMB7 (kindly provided by Mike Boxem) and microinjected into
C. elegans with a myo2::mCherry cotransformation marker. Overexpression
was induced using a 30 min heat shock at 35C. Following heat shock worms
were allowed to lay eggs for 24 hr at 20C and then removed from the wells.
Embryonic lethality was scored 24 hr later. A strain with heat-shock-inducible
expression of green fluorescent protein (TJ375; Rea et al., 2005) was used as
an internal control in all experiments.
Human and Mouse Datasets
Mouse oncogenes activated by retrovirus insertions are from the RTCGDdata-
base (http://rtcgd.abcc.ncifcrf.gov/), a total of 460 genes (Akagi et al., 2004),
excluding all insertions that disrupt open reading frames. Human oncogenes
activated by amplification (n = 9) or translocation (n = 263) are from the Sanger
Cancer Gene Census (Futreal et al., 2004) (http://www.sanger.ac.uk/genetics/
CGP/Census/). Motif-binding domains, linear motifs, and disorder were
defined as for Drosophila. Human protein interaction data were taken from
an integration of 21 different databases (Bossi and Lehner, 2009) and filtered
to only include binary interactions detected by two-hybrid assays, removing
interactions also detected in complex purification methods (a total of 13,352
interactions). The same interaction dataset was used for mouse, using 1:1
orthology relationships identified by Ensembl.
SUPPLEMENTAL DATA
SupplementalData includefivefiguresandfive tables andcanbe foundwith this
article online at http://www.cell.com/supplemental/S0092-8674(09)00454-1.
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